CIS School in Systemic Autoimmune Diseases

描述（由申请人提供）：概要此补助金要求支持研究员参加2009年，2010年和2011年临床免疫学会（CIS）系统性自身免疫疾病学校的差旅费和费用。这项补助金被要求帮助支付美国的费用。研究员旅行和与上学有关的费用。将向制药和生物技术公司寻求额外资金。接下来的三个节目定于春季在马萨诸塞州的波士顿举行。这项活动的目的是达到国际目标受众，包括来自美国，欧洲和亚洲的培训研究员持有MD和/或博士学位，并在他们的研究金培训的最后几年。十名教师和二十五名研究员将被选中参加每个学校。该计划将通过CIS和美国流变学学院的学术项目主任和成员以及其他对临床免疫学感兴趣的主要学会进行宣传。将强调广告宣传，以吸引代表少数群体的申请人。学校的目标是提高服务员诊断和治疗系统性自身免疫性疾病的能力;提高他们对与系统性自身免疫性疾病有关的免疫病理过程的理解;熟悉科学发现转化为临床实践的重要性;促进年轻研究员在系统性自身免疫性疾病研究中追求学术事业的雄心。最后，学校旨在促进不同医学中心和国家的年轻研究人员之间的未来合作，以及年轻研究人员和该领域经验丰富的医生/科学家之间的合作。

DESCRIPTION (provided by applicant): SUMMARY This grant requests support for travel and expenses of fellows to attend the 2009, 2010, and 2011 Clinical Immunology Society (CIS) School in Systemic Autoimmune Diseases. This grant is requested to help defray costs for U.S. fellow travel and expenses related to attending the School. Additional funding will be solicited from pharmaceutical and biotechnology companies. The next three programs are scheduled to take place during the spring in Boston, Massachusetts. This activity is intended to reach an international target audience consisting of fellows-in-training from America, Europe, and Asia holding either an MD and/or a PhD and within their last years of fellowship training. Ten faculty and twenty-five fellows will be selected to attend each School. The program will be advertised through academic program directors and members of the CIS and the American College of Rheumatology as well as through other major societies with interests in clinical immunology. Advertising emphasis will be given to attract applicants representing minorities. The objective of the School is to enhance the ability of the attendants to diagnose and treat systemic autoimmune diseases; to improve their understanding of immunopathogenic processes as they relate to systemic autoimmune diseases; to familiarize with the importance of scientific discoveries as they translate into clinical practice; to promote ambition among young fellows to pursue academic careers in the study of systemic autoimmune diseases. Lastly, the School is designed to stimulate future collaborations between young investigators in different medical centers and countries, and between young investigators and experienced physician/scientists in the field.